White Paper
Drug and Device Accountability Act of 2008: How Execs can Avoid Jail Time
Loading Content
About this Document
Pharmaceutical and medical device companies are being held to a higher accountability under the Drug and Device Accountability Act of 2008. This white paper discusses the bill, including ways senior executives of life science companies can protect themselves against inadvertently certifying information that could be deemed misleading or inaccurate.
PDF
— 0.26MB
